Reminder Messages and Patient Navigation for Neurodevelopmental Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to reduce missed appointments for individuals with neurodevelopmental disorders, such as autism, by testing various reminder messages and the assistance of patient navigators. Researchers seek to determine which reminder strategies are most effective and whether a dedicated assistant (patient navigator) increases appointment attendance. The trial includes several groups, each receiving different combinations of reminder messages and navigator support, to identify the most effective approach. Those who might benefit include individuals scheduled for evaluations at centers specializing in autism or psychological assessments and who frequently miss appointments. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to a potentially groundbreaking solution for improving appointment adherence.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that reminder messages and patient navigation can safely and effectively help people attend their medical appointments. Studies have found that text message reminders greatly improve attendance. For instance, one study found that attendance rates increased to 85.7% with SMS reminders.
Patient navigation programs are generally well-received. They guide patients through the healthcare system by providing support and information, leading to higher satisfaction.
Both reminder messages and patient navigation are non-invasive, involving no physical procedures and generally safe. These methods aim to improve patient interaction with healthcare services, with minimal risk of negative effects.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to reduce missed appointments for individuals with neurodevelopmental disorders. Unlike the usual reminder systems that simply provide basic appointment details, this trial tests enhanced reminder messages crafted from scientific literature, aiming to better engage patients. Additionally, some trial arms include personal assistance with appointment navigation, offering an extra layer of support that could significantly boost attendance. By comparing these various approaches, the study seeks to uncover the most effective strategies for ensuring patients attend their appointments, which is critical for their ongoing care and management.
What evidence suggests that this trial's treatments could be effective for reducing missed appointments in neurodevelopmental disorders?
Research has shown that reminder messages, especially through mobile phones, can help reduce missed healthcare appointments. One study found that text message reminders were the most effective, significantly lowering the number of missed appointments. Another review highlighted that technology-based reminders reduced missed appointments by 5–10%.
In this trial, participants will receive different types of reminder messages. Some will receive enhanced messages, while others will receive standard messages. Additionally, certain arms will include patient navigation, where personal guidance and assistance are provided. Studies suggest this offers extra benefits, especially for families at risk of missing appointments. Overall, combining reminder messages with patient navigation has shown promise in improving attendance and reducing missed appointments.13678Who Is on the Research Team?
luther G kalb, PhD
Principal Investigator
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Are You a Good Fit for This Trial?
This trial is for individuals with neurodevelopmental disorders who often miss their medical appointments. Specific eligibility criteria are not provided, but typically participants would need to have a confirmed diagnosis and be able to receive communications for reminders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive different appointment reminder messages and patient navigation services to reduce missed appointments
Follow-up
Participants are monitored for appointment attendance and barriers to attendance are assessed
What Are the Treatments Tested in This Trial?
Interventions
- Reducing Missed Appointments
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Lead Sponsor